Hodgkin’s Lymphoma: The Hidden Cancer Behind Persistent Cough, Weight Loss, and Mediastinal Masses — A Radiology-Guided Diagnostic Approach
Hodgkin’s Lymphoma: A Radiologist’s Perspective on Diagnosis, Imaging, and Survival
A Clinical Story That Began With a Persistent Cough
A 41-year-old man arrived at the emergency department with symptoms that had slowly worsened over nine months.
Initially, he experienced a mild cough.
Then came exertional dyspnea.
Soon afterward, he developed night sweats and an unexplained 10-kg weight loss.
Physical examination revealed extensive painless cervical and supraclavicular lymphadenopathy. Chest radiography demonstrated bilateral hilar enlargement, raising immediate concern for a serious thoracic pathology. Subsequent CT imaging revealed extensive mediastinal, hilar, and axillary lymphadenopathy. Excisional lymph node biopsy ultimately confirmed nodular sclerosis Hodgkin’s lymphoma, the most common subtype of classical Hodgkin lymphoma.
This case illustrates why medical imaging, particularly CT scan diagnosis and radiology interpretation, remains indispensable in the evaluation of unexplained mediastinal masses and lymphadenopathy.
What Is Hodgkin’s Lymphoma?
Hodgkin’s lymphoma (HL) is a malignant neoplasm of the lymphatic system characterized by the presence of Reed-Sternberg cells, giant abnormal B lymphocytes that drive a unique inflammatory microenvironment.
First described by Thomas Hodgkin in 1832, Hodgkin lymphoma accounts for approximately 10% of all lymphomas and remains one of the most curable human cancers when diagnosed early.
Epidemiology
Global Incidence
Hodgkin lymphoma affects approximately:
2–3 individuals per 100,000 annually
Young adults (15–35 years)
Older adults (>55 years)
The disease exhibits a characteristic bimodal age distribution.
Risk Factors
Epstein-Barr virus (EBV) infection
Family history
Immunosuppression
HIV infection
Autoimmune disorders
Pathophysiology
The Reed-Sternberg Cell
The hallmark of Hodgkin lymphoma is the Reed-Sternberg (RS) cell.
These cells:
Originate from germinal-center B lymphocytes
Lose normal B-cell function
Secrete cytokines
Recruit inflammatory cells
The tumor itself often consists of only a small number of malignant cells surrounded by:
Lymphocytes
Plasma cells
Eosinophils
Macrophages
This unique biology explains many clinical manifestations.
Major Histologic Types
Classical Hodgkin Lymphoma (95%)
Subtypes include:
Nodular sclerosis
Mixed cellularity
Lymphocyte-rich
Lymphocyte-depleted
Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
A biologically distinct entity with different immunophenotypic characteristics.
Clinical Presentation
Common Symptoms
Patients often present with:
Lymphadenopathy
Typically:
Painless
Cervical
Supraclavicular
Mediastinal
Constitutional "B Symptoms"
Fever
Night sweats
Weight loss
The patient in our case exhibited both night sweats and significant weight loss.
Other Symptoms
Chronic cough
Dyspnea
Chest discomfort
Fatigue
Pruritus
Why This Case Was Unusual: Severe Hypercalcemia
One remarkable feature was profound hypercalcemia:
Serum calcium: 16.2 mg/dL
This required emergency treatment with:
Intravenous saline
Bisphosphonates
Laboratory testing also demonstrated markedly elevated LDH.
Although uncommon, Hodgkin lymphoma may cause hypercalcemia through dysregulated vitamin D activation by tumor-associated macrophages.
Imaging of Hodgkin’s Lymphoma
Medical imaging plays a pivotal role in:
Detection
Staging
Treatment planning
Response assessment
Figure 1. Chest Radiograph Findings
Chest PA radiograph demonstrating bilateral hilar enlargement (arrows), representing extensive hilar lymphadenopathy.
Radiologic Interpretation
The chest X-ray demonstrates:
Bilateral hilar masses
Symmetric hilar enlargement
Mediastinal widening
Such findings strongly suggest:
Lymphoma
Sarcoidosis
Metastatic nodal disease
In this case, bilateral hilar lymphadenopathy represented nodal involvement by Hodgkin lymphoma.
Diagnostic Contribution
Chest radiography served as the first clue leading to advanced cross-sectional imaging.
Figure 2. Contrast-Enhanced CT Findings
Axial contrast-enhanced CT image showing bulky mediastinal and hilar lymphadenopathy (arrows).
Radiologic Interpretation
CT demonstrates:
Large confluent mediastinal nodal masses
Bilateral hilar adenopathy
Compression of adjacent thoracic structures
Extensive supradiaphragmatic disease
The patient's CT confirmed:
Hilar lymphadenopathy
Mediastinal lymphadenopathy
Axillary lymphadenopathy
above the diaphragm.
Diagnostic Contribution
CT imaging:
Defined disease extent
Guided biopsy selection
Provided Ann Arbor staging information
This is a classic example of how CT scan diagnosis dramatically improves diagnostic confidence.
Characteristic CT Imaging Features
Thoracic Findings
The chest is involved in over 80% of patients.
Typical CT findings include:
| Feature | Frequency |
|---|---|
| Mediastinal lymphadenopathy | Very common |
| Hilar lymphadenopathy | Common |
| Axillary nodes | Common |
| Large nodal conglomerates | Common |
| Pleural effusion | Occasional |
Mediastinal Distribution
Most commonly affected stations:
Paratracheal
Prevascular
Aortopulmonary window
Hilar nodes
Extranodal Disease
Less common than in non-Hodgkin lymphoma.
Possible sites:
Lung
Liver
Spleen
Bone marrow
PET/CT: The Modern Standard
Although CT remains the foundation of staging, PET/CT is now considered essential.
PET/CT allows:
Metabolic assessment
Whole-body staging
Treatment response monitoring
The Deauville scoring system is widely used.
| Score | Interpretation |
|---|---|
| 1–3 | Complete response |
| 4–5 | Residual active disease |
Differential Diagnosis
Several conditions can mimic Hodgkin lymphoma radiologically.
1. Sarcoidosis
Similarities:
Bilateral hilar adenopathy
Differences:
Usually lacks bulky mediastinal masses
Noncaseating granulomas on biopsy
2. Tuberculosis
Findings:
Necrotic lymph nodes
Pulmonary infiltrates
3. Non-Hodgkin Lymphoma
Compared with HL:
More extranodal disease
Less predictable nodal spread
4. Metastatic Lung Cancer
Particularly:
Small-cell carcinoma
Squamous-cell carcinoma
These were included among the differential considerations in the original case discussion.
Diagnostic Workflow
Step 1: Clinical Suspicion
Red-flag symptoms:
✓ Persistent lymphadenopathy
✓ Night sweats
✓ Weight loss
✓ Chronic cough
Step 2: Initial Imaging
Chest X-Ray
Detects:
Hilar enlargement
Mediastinal widening
Step 3: CT Scan Diagnosis
Defines:
Disease distribution
Node size
Organ involvement
Step 4: PET/CT
Determines:
Metabolic activity
Staging
Step 5: Histopathology
Gold standard.
Biopsy identifies:
Reed-Sternberg cells
Histologic subtype
The patient underwent axillary lymph node excisional biopsy confirming nodular sclerosis Hodgkin lymphoma.
Ann Arbor Staging System
| Stage | Description |
|---|---|
| I | Single nodal region |
| II | ≥2 regions same side diaphragm |
| III | Both sides diaphragm |
| IV | Diffuse extranodal involvement |
Additional designation:
A = No B symptoms
B = Fever, night sweats, weight loss
Treatment
ABVD Chemotherapy
The traditional first-line regimen:
Adriamycin (Doxorubicin)
Bleomycin
Vinblastine
Dacarbazine
The patient described in this case demonstrated an excellent response after 8 months of ABVD therapy.
Radiation Therapy
Used for:
Early-stage disease
Consolidation after chemotherapy
Immunotherapy
Modern agents include:
Brentuximab vedotin
PD-1 inhibitors
Examples:
Nivolumab
Pembrolizumab
Stem Cell Transplantation
Reserved for:
Relapsed disease
Refractory disease
Prognosis
Hodgkin lymphoma is among the most curable cancers.
Five-Year Survival
| Stage | Survival |
|---|---|
| Localized | >90% |
| Regional | 85–90% |
| Advanced | 75–85% |
Factors associated with worse outcomes:
Advanced stage
High LDH
Older age
Extensive extranodal disease
Key Radiology Pearls
When You See Bilateral Hilar Lymphadenopathy
Always consider:
Hodgkin lymphoma
Sarcoidosis
Tuberculosis
Metastatic disease
When You See Bulky Mediastinal Masses in Young Adults
Think first about:
Hodgkin lymphoma
Primary mediastinal B-cell lymphoma
Germ cell tumors
Key Takeaways
✅ Hodgkin lymphoma is characterized by Reed-Sternberg cells.
✅ CT is the cornerstone of staging and radiology interpretation.
✅ Mediastinal lymphadenopathy is the most common thoracic manifestation.
✅ PET/CT is critical for response assessment.
✅ ABVD chemotherapy achieves excellent cure rates.
✅ Early diagnosis dramatically improves survival.
Quiz
Question 1. A 25-year-old patient presents with painless cervical lymphadenopathy and mediastinal widening on chest radiography. Which diagnosis is most likely?
A. Tuberculosis
B. Hodgkin lymphoma
C. Pulmonary embolism
D. COPD
E. Pneumothorax
Correct Answer: B. Hodgkin lymphoma. Explanation: Young adults with painless lymphadenopathy and mediastinal adenopathy classically suggest Hodgkin lymphoma.
Question 2. Which imaging modality is most important for initial staging?
A. Ultrasound
B. Mammography
C. PET/CT
D. Fluoroscopy
E. Echocardiography
Correct Answer: C. PET/CT. Explanation: PET/CT provides both anatomic and metabolic assessment and is the current standard for staging.
Question 3. Which cell type is pathognomonic for Hodgkin lymphoma?
A. Plasma cell
B. Neutrophil
C. Reed-Sternberg cell
D. Fibroblast
E. Eosinophil
Correct Answer: C. Reed-Sternberg cell. Explanation: The Reed-Sternberg cell is the defining histopathologic feature of Hodgkin lymphoma.
Frequently Asked Questions (FAQ)
Can Hodgkin lymphoma be cured?
Yes. Cure rates exceed 90% in many early-stage patients.
Is CT or MRI better?
CT remains the primary imaging tool for staging and surveillance. MRI has selected roles but is not routinely used.
What are the first symptoms?
Most patients notice:
Enlarged lymph nodes
Night sweats
Fever
Weight loss
Is Hodgkin lymphoma hereditary?
Most cases are sporadic, although family history may increase risk.
What does radiology typically show?
Typical findings include:
Mediastinal masses
Hilar lymphadenopathy
Enlarged cervical nodes
PET-avid disease
Recommended Reading
A. Engert et al., "Reduced Treatment Intensity in Patients With Early-Stage Hodgkin's Lymphoma," New England Journal of Medicine, vol. 363, no. 7, pp. 640–652, 2010. DOI: https://doi.org/10.1056/NEJMoa1000067
P. Johnson et al., "Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin's Lymphoma," New England Journal of Medicine, vol. 374, pp. 2419–2429, 2016. DOI: https://doi.org/10.1056/NEJMoa1510093
S. Barrington and S. Mikhaeel, "When Should FDG PET-CT Be Used in the Modern Management of Lymphoma?" British Journal of Haematology, vol. 164, pp. 315–328, 2014. DOI: https://doi.org/10.1111/bjh.12602
B. Cheson et al., "Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma," Journal of Clinical Oncology, vol. 32, pp. 3059–3068, 2014. DOI: https://doi.org/10.1200/JCO.2013.54.8800
A. Eichenauer et al., "Hodgkin Lymphoma: ESMO Clinical Practice Guidelines," Annals of Oncology, vol. 29, Suppl 4, 2018. DOI: https://doi.org/10.1093/annonc/mdy080
S. Ansell, "Hodgkin Lymphoma: Diagnosis and Treatment," Mayo Clinic Proceedings, vol. 90, no. 11, pp. 1574–1583, 2015. DOI: https://doi.org/10.1016/j.mayocp.2015.07.005
A. Evens and J. Hutchings, "Hodgkin Lymphoma," The Lancet, vol. 390, pp. 2790–2802, 2017. DOI: https://doi.org/10.1016/S0140-6736(17)32262-9
K. Kwee and T. Kwee, "Combined FDG-PET/CT for the Detection of Bone Marrow Involvement in Hodgkin Lymphoma," European Radiology, vol. 21, pp. 274–282, 2011. DOI: https://doi.org/10.1007/s00330-010-1919-0
Comments
Post a Comment